186 related articles for article (PubMed ID: 37550785)
41. Autotaxin and LPA receptors represent potential molecular targets for the radiosensitization of murine glioma through effects on tumor vasculature.
Schleicher SM; Thotala DK; Linkous AG; Hu R; Leahy KM; Yazlovitskaya EM; Hallahan DE
PLoS One; 2011; 6(7):e22182. PubMed ID: 21799791
[TBL] [Abstract][Full Text] [Related]
42. Hydroxamic Acids Constitute a Novel Class of Autotaxin Inhibitors that Exhibit in Vivo Efficacy in a Pulmonary Fibrosis Model.
Nikolaou A; Ninou I; Kokotou MG; Kaffe E; Afantitis A; Aidinis V; Kokotos G
J Med Chem; 2018 Apr; 61(8):3697-3711. PubMed ID: 29620892
[TBL] [Abstract][Full Text] [Related]
43. Increased Autotaxin Levels in Severe COVID-19, Correlating with IL-6 Levels, Endothelial Dysfunction Biomarkers, and Impaired Functions of Dendritic Cells.
Nikitopoulou I; Fanidis D; Ntatsoulis K; Moulos P; Mpekoulis G; Evangelidou M; Vassiliou AG; Dimakopoulou V; Jahaj E; Tsipilis S; Orfanos SE; Dimopoulou I; Angelakis E; Akinosoglou K; Vassilaki N; Tzouvelekis A; Kotanidou A; Aidinis V
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576169
[TBL] [Abstract][Full Text] [Related]
44. Boronic acid-based inhibitor of autotaxin reveals rapid turnover of LPA in the circulation.
Albers HM; Dong A; van Meeteren LA; Egan DA; Sunkara M; van Tilburg EW; Schuurman K; van Tellingen O; Morris AJ; Smyth SS; Moolenaar WH; Ovaa H
Proc Natl Acad Sci U S A; 2010 Apr; 107(16):7257-62. PubMed ID: 20360563
[TBL] [Abstract][Full Text] [Related]
45. Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production.
Umezu-Goto M; Kishi Y; Taira A; Hama K; Dohmae N; Takio K; Yamori T; Mills GB; Inoue K; Aoki J; Arai H
J Cell Biol; 2002 Jul; 158(2):227-33. PubMed ID: 12119361
[TBL] [Abstract][Full Text] [Related]
46. Autotaxin in ascites promotes peritoneal dissemination in pancreatic cancer.
Jinno N; Yoshida M; Hayashi K; Naitoh I; Hori Y; Natsume M; Kato A; Kachi K; Asano G; Atsuta N; Sahashi H; Kataoka H
Cancer Sci; 2021 Feb; 112(2):668-678. PubMed ID: 33053268
[TBL] [Abstract][Full Text] [Related]
47. The autotaxin-lysophosphatidic acid-lysophosphatidic acid receptor cascade: proposal of a novel potential therapeutic target for treating glioblastoma multiforme.
Tabuchi S
Lipids Health Dis; 2015 Jun; 14():56. PubMed ID: 26084470
[TBL] [Abstract][Full Text] [Related]
48. Development and therapeutic potential of autotaxin small molecule inhibitors: From bench to advanced clinical trials.
Matralis AN; Afantitis A; Aidinis V
Med Res Rev; 2019 May; 39(3):976-1013. PubMed ID: 30462853
[TBL] [Abstract][Full Text] [Related]
49. Role of the autotaxin-lysophosphatidate axis in the development of resistance to cancer therapy.
Tang X; Benesch MGK; Brindley DN
Biochim Biophys Acta Mol Cell Biol Lipids; 2020 Aug; 1865(8):158716. PubMed ID: 32305571
[TBL] [Abstract][Full Text] [Related]
50. Pharmacologic targeting of the ATX/LPA axis attenuates bleomycin-induced pulmonary fibrosis.
Ninou I; Kaffe E; Müller S; Budd DC; Stevenson CS; Ullmer C; Aidinis V
Pulm Pharmacol Ther; 2018 Oct; 52():32-40. PubMed ID: 30201409
[TBL] [Abstract][Full Text] [Related]
51. Ligand-based autotaxin pharmacophore models reflect structure-based docking results.
Mize CD; Abbott AM; Gacasan SB; Parrill AL; Baker DL
J Mol Graph Model; 2011 Nov; 31():76-86. PubMed ID: 21967734
[TBL] [Abstract][Full Text] [Related]
52. Autotaxin production of lysophosphatidic acid mediates allergic asthmatic inflammation.
Park GY; Lee YG; Berdyshev E; Nyenhuis S; Du J; Fu P; Gorshkova IA; Li Y; Chung S; Karpurapu M; Deng J; Ranjan R; Xiao L; Jaffe HA; Corbridge SJ; Kelly EA; Jarjour NN; Chun J; Prestwich GD; Kaffe E; Ninou I; Aidinis V; Morris AJ; Smyth SS; Ackerman SJ; Natarajan V; Christman JW
Am J Respir Crit Care Med; 2013 Oct; 188(8):928-40. PubMed ID: 24050723
[TBL] [Abstract][Full Text] [Related]
53. Design, synthesis and promising anti-tumor efficacy of novel imidazo[1,2-a]pyridine derivatives as potent autotaxin allosteric inhibitors.
Lei H; Wang X; Zhao G; Li T; Cui Y; Wu H; Yang J; Jiang N; Zhai X
Eur J Med Chem; 2022 Jun; 236():114307. PubMed ID: 35436669
[TBL] [Abstract][Full Text] [Related]
54. Development of lysophosphatidic acid pathway modulators as therapies for fibrosis.
Budd DC; Qian Y
Future Med Chem; 2013 Oct; 5(16):1935-52. PubMed ID: 24175745
[TBL] [Abstract][Full Text] [Related]
55. Autotaxin inhibition reduces cardiac inflammation and mitigates adverse cardiac remodeling after myocardial infarction.
Tripathi H; Al-Darraji A; Abo-Aly M; Peng H; Shokri E; Chelvarajan L; R Donahue R; Levitan BM; Gao E; Hernandez G; Morris AJ; Smyth SS; Abdel-Latif A
J Mol Cell Cardiol; 2020 Dec; 149():95-114. PubMed ID: 33017574
[TBL] [Abstract][Full Text] [Related]
56. Benzyl and naphthalene methylphosphonic acid inhibitors of autotaxin with anti-invasive and anti-metastatic activity.
Gupte R; Patil R; Liu J; Wang Y; Lee SC; Fujiwara Y; Fells J; Bolen AL; Emmons-Thompson K; Yates CR; Siddam A; Panupinthu N; Pham TC; Baker DL; Parrill AL; Mills GB; Tigyi G; Miller DD
ChemMedChem; 2011 May; 6(5):922-35. PubMed ID: 21465666
[TBL] [Abstract][Full Text] [Related]
57. Establishment of a novel, cell-based autotaxin assay.
Dobersalske C; Grundmann M; Timmermann A; Theisen L; Kölling F; Harris RC; Fuerstner C; Becker MS; Wunder F
Anal Biochem; 2021 Oct; 630():114322. PubMed ID: 34343482
[TBL] [Abstract][Full Text] [Related]
58. Roles of Autotaxin/Autotaxin-Lysophosphatidic Acid Axis in the Initiation and Progression of Liver Cancer.
She S; Zhang Q; Shi J; Yang F; Dai K
Front Oncol; 2022; 12():922945. PubMed ID: 35769713
[TBL] [Abstract][Full Text] [Related]
59. Inhibition of autotaxin production or activity blocks lysophosphatidylcholine-induced migration of human breast cancer and melanoma cells.
Gaetano CG; Samadi N; Tomsig JL; Macdonald TL; Lynch KR; Brindley DN
Mol Carcinog; 2009 Sep; 48(9):801-9. PubMed ID: 19204929
[TBL] [Abstract][Full Text] [Related]
60. NSun2 promotes cell migration through methylating autotaxin mRNA.
Xu X; Zhang Y; Zhang J; Zhang X
J Biol Chem; 2020 Dec; 295(52):18134-18147. PubMed ID: 33093178
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
